566 related articles for article (PubMed ID: 8433041)
1. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
[TBL] [Abstract][Full Text] [Related]
2. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
5. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
6. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
Orłowski A; Szepietowski T
Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
8. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
[TBL] [Abstract][Full Text] [Related]
10. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear oxygen free radical production and complement activation induced by dialysis membranes as assayed in an experimental model.
Cappelli G; Lucchi L; Bonucchi D; Cenci AM; Montagnani G; De Palma M; Lusvarghi E
Blood Purif; 1989; 7(6):293-300. PubMed ID: 2611000
[TBL] [Abstract][Full Text] [Related]
12. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
13. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
14. Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition.
Igarashi H; Kioi S; Gejyo F; Arakawa M
Nephron; 1985; 41(1):62-9. PubMed ID: 3929152
[TBL] [Abstract][Full Text] [Related]
15. Research on dialyzers with improved biocompatibility.
van der Steen A
Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
[TBL] [Abstract][Full Text] [Related]
16. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
[TBL] [Abstract][Full Text] [Related]
17. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
Lonnemann G; Koch KM; Shaldon S; Dinarello CA
J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
[TBL] [Abstract][Full Text] [Related]
18. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
[TBL] [Abstract][Full Text] [Related]
19. Is the dialysate fluid source of complement activating factors?
Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
[TBL] [Abstract][Full Text] [Related]
20. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
